Re:Biomarker for chronic fatigue syndrome identified
by Someone on Sunday May 05, 2019 @05:24PM
(#19835173)
Learning about them: https://en.wikipedia.org/wiki/Support-vector_machine.
That will tell you SVMs are ancient (linear version dates back to 1963), and that what they do here isn’t really machine learning, but something similar to linear regression: just as linear regression finds the best (in some strict mathematical sense) line describing a set of points, this finds the best (in a similar mathematical sense) line splitting two sets of points.
For software, take a look at https://www.csie.ntu.edu.tw/~cjlin/libsvm/. Easy to use, fairly flexible, with a Java applet you can play with.
Re:Biomarker for chronic fatigue syndrome identified
by verroq on Sunday May 05, 2019 @01:09PM
(#19833748)
SVMs are as old school ML as they get. They guarentee the maximum separation at the decision boundary. However it doesn’t scale very well for higher dimensional data. The standard used to be to use some dimensionality reduction technique like PCA to preprocess before feeding it into the SVM.
This is all before deep learning.
I guess my question comes from the observation that these advanced statistical techniques such as machine learning haven't been around for long and yet medicine has often created decision boundaries, presumably just looking at the data and making a reasonable cutoff. Is all the extra effort in a case like this worth the time investment?